These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 32979687

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
    Waldner MJ, Neurath MF.
    Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
    [Abstract] [Full Text] [Related]

  • 24. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer.
    Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ.
    Cytokine Growth Factor Rev; 2012 Jun; 23(3):127-38. PubMed ID: 22591635
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
    Isidro RA, Cruz ML, Isidro AA, Baez A, Arroyo A, González-Marqués WA, González-Keelan C, Torres EA, Appleyard CB.
    World J Gastroenterol; 2015 Feb 14; 21(6):1749-58. PubMed ID: 25684939
    [Abstract] [Full Text] [Related]

  • 29. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer.
    Atreya R, Neurath MF.
    Curr Drug Targets; 2008 May 14; 9(5):369-74. PubMed ID: 18473764
    [Abstract] [Full Text] [Related]

  • 30. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.
    Ahmad R, Kumar B, Chen Z, Chen X, Müller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB.
    Oncogene; 2017 Nov 23; 36(47):6592-6604. PubMed ID: 28783170
    [Abstract] [Full Text] [Related]

  • 31. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C, Zhao X, Gu H, Huang L, Zhou S, Zhi F.
    Med Sci Monit; 2016 Dec 07; 22():4794-4802. PubMed ID: 27926694
    [Abstract] [Full Text] [Related]

  • 32. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
    Usaj S, Tarabar D, Cuk V, Cerovic S, Brajukovic G, Panisic M, Klem I, Eric Z.
    Acta Chir Iugosl; 2004 Dec 07; 51(2):109-16. PubMed ID: 15771301
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.
    Schreiber S, Aden K, Bernardes JP, Conrad C, Tran F, Höper H, Volk V, Mishra N, Blase JI, Nikolaus S, Bethge J, Kühbacher T, Röcken C, Chen M, Cottingham I, Petri N, Rasmussen BB, Lokau J, Lenk L, Garbers C, Feuerhake F, Rose-John S, Waetzig GH, Rosenstiel P.
    Gastroenterology; 2021 Jun 07; 160(7):2354-2366.e11. PubMed ID: 33667488
    [Abstract] [Full Text] [Related]

  • 34. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model.
    Kim G, Ouzounova M, Quraishi AA, Davis A, Tawakkol N, Clouthier SG, Malik F, Paulson AK, D'Angelo RC, Korkaya S, Baker TL, Esen ES, Prat A, Liu S, Kleer CG, Thomas DG, Wicha MS, Korkaya H.
    Oncogene; 2015 Feb 05; 34(6):671-80. PubMed ID: 24531711
    [Abstract] [Full Text] [Related]

  • 35. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease.
    Rubio CA, Befrits R, Jaramillo E, Nesi G, Amorosi A.
    Anticancer Res; 2000 Feb 05; 20(6C):4761-4. PubMed ID: 11205214
    [Abstract] [Full Text] [Related]

  • 36. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.
    Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L.
    Gut; 1996 Mar 05; 38(3):414-20. PubMed ID: 8675096
    [Abstract] [Full Text] [Related]

  • 37. STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.
    Willson TA, Kuhn BR, Jurickova I, Gerad S, Moon D, Bonkowski E, Carey R, Collins MH, Xu H, Jegga AG, Guthery SL, Denson LA.
    J Pediatr Gastroenterol Nutr; 2012 Jul 05; 55(1):32-43. PubMed ID: 22197944
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of SOCS3 and its biological function in colorectal cancer.
    Chu Q, Shen D, He L, Wang H, Liu C, Zhang W.
    Gene; 2017 Sep 05; 627():114-122. PubMed ID: 28603075
    [Abstract] [Full Text] [Related]

  • 39. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT, Salomao M, Zhao L, Alpert L, Setia N, Liao X, Drage MG, Westerhoff M, Cheng J, Lauwers GY, Ko HM.
    J Crohns Colitis; 2022 Jan 28; 16(1):98-108. PubMed ID: 34232295
    [Abstract] [Full Text] [Related]

  • 40. Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway.
    Saadatdoust Z, Pandurangan AK, Ananda Sadagopan SK, Mohd Esa N, Ismail A, Mustafa MR.
    J Nutr Biochem; 2015 Dec 28; 26(12):1547-58. PubMed ID: 26355019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.